LITAF Gene CMT1C NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Neuropathy
The LITAF Gene CMT1C NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the LITAF (Lipopolysaccharide-Induced TNF Factor) gene associated with Charcot-Marie-Tooth disease type 1C. This inherited peripheral neuropathy affects approximately 1 in 2,500 people worldwide and follows an autosomal dominant inheritance pattern. Our advanced testing methodology provides definitive answers for patients and families affected by this progressive neurological condition.
What Does the LITAF Gene CMT1C Test Detect?
This sophisticated genetic analysis specifically targets:
- Pathogenic variants in the LITAF gene on chromosome 16p13.1-p12.3
- Single nucleotide polymorphisms (SNPs) affecting protein function
- Insertions, deletions, and copy number variations
- Mutations that disrupt normal myelin sheath formation in peripheral nerves
- Genetic markers associated with progressive nerve degeneration
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals experiencing:
- Progressive muscle weakness in feet and lower legs
- High-arched feet (pes cavus) or hammer toes
- Reduced sensation in extremities
- Difficulty with balance and coordination
- Family history of peripheral neuropathy
- Unexplained foot drop or abnormal gait
- Muscle atrophy in hands and feet
- Delayed motor development in childhood
Clinical Benefits of LITAF Gene Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Definitive Diagnosis: Confirms or rules out CMT1C with high accuracy
- Family Planning: Enables informed reproductive decisions
- Early Intervention: Facilitates proactive management strategies
- Treatment Guidance: Helps neurologists develop targeted care plans
- Genetic Counseling: Provides family risk assessment and education
- Research Contribution: Advances understanding of hereditary neuropathies
Understanding Your Test Results
Our comprehensive reporting includes:
- Positive Result: Indicates presence of LITAF gene mutation associated with CMT1C
- Negative Result: Suggests absence of tested mutations but doesn’t rule out other CMT subtypes
- Variant of Uncertain Significance: Requires additional family studies for interpretation
- Genetic Counseling: All results include professional interpretation and guidance
Test Pricing and Details
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Turnaround Time | 3-4 Weeks |
| Sample Type | Blood, Extracted DNA, or Blood on FTA Card |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.
Take Control of Your Neurological Health Today
Don’t let uncertainty about hereditary neuropathy affect your quality of life. Our expert team of genetic counselors and neurologists are ready to guide you through the testing process and help you understand your results. Early diagnosis can significantly impact treatment outcomes and family planning decisions.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your LITAF Gene CMT1C NGS Genetic DNA Test and take the first step toward definitive answers about your neurological health.
